Public Calendar for the week of 12/15/2024 - 12/21/2024
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs
Event Date: 12/16/2024
Location: Virtual
Subject: National Academy of Medicine Action Collaborative on Translating Equitable Science, Technology, and Innovation
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other invited attendees
Event Date: 12/17/2024
Location: Bethesda, MD
Subject: NIH-FDA Nutrition Regulatory Science Workshop; Speaker: Opening Remarks
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, academia, industry, and other invited attendees
Event Date: 12/18/2024
Location: Silver Spring, MD
Subject: Drug Shortages
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Akash Jain, Eliana Schleifer, Philomena Fritz, Remick Kawawaki (Palantir);
Event Date: 12/18/2024
Location: Virtual
Subject: Food Safety Inspection Strategy; Accredited Third-Party Certification Program
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry and other invited guests
Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner
No Significant Event
Official Name: Jim Jones, Deputy Commissioner for Human Foods
Event Date: 12/19/2024
Location: Washington, DC
Subject: Human Foods Program
FDA Participant/Group: LAUREN STUMP;
Non FDA Participant/Group: Senator Roger Marshall (R-KS)
Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs
Event Date: 12/17/2024
Location: Washington, DC
Subject: Avenue Solutions Holiday Party
FDA Participant/Group: N/A
Non FDA Participant/Group: Widely attended gathering
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Michael Rogers, Associate Commissioner for Inspections and Investigations
No Significant Event
Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research
No Significant Event
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 12/18/2024
Location: Virtual
Subject: The 9th Princess Chulabhorn International Science Congress - The Challenges of One Health: The Roles of Biosciences and Chemistry; Speaker: FDA's Efforts to Advance the Development of Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees
Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name: Brian King, Ph.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine
No Significant Event
Official Name: Mark Raza, J.D., Chief Counsel
No Significant Event